Extension of life-span by introduction of telomerase into normal human cells AG Bodnar, M Ouellette, M Frolkis, SE Holt, CP Chiu, GB Morin, ... science 279 (5349), 349-352, 1998 | 6753 | 1998 |
Telomerase catalytic subunit homologs from fission yeast and human TM Nakamura, GB Morin, KB Chapman, SL Weinrich, WH Andrews, ... Science 277 (5328), 955-959, 1997 | 3143 | 1997 |
The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 2330 | 2012 |
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats GB Morin cell 59 (3), 521-529, 1989 | 2224 | 1989 |
ARID1A mutations in endometriosis-associated ovarian carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1970 | 2010 |
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT SL Weinrich, R Pruzan, L Ma, M Ouellette, VM Tesmer, SE Holt, ... Nature genetics 17 (4), 498-502, 1997 | 1340 | 1997 |
Large‐scale mapping of human protein–protein interactions by mass spectrometry RM Ewing, P Chu, F Elisma, H Li, P Taylor, S Climie, ... Molecular systems biology 3 (1), 89, 2007 | 1250 | 2007 |
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments CS Hughes, S Moggridge, T Müller, PH Sorensen, GB Morin, J Krijgsveld Nature protocols 14 (1), 68-85, 2019 | 1240 | 2019 |
Functional requirement of p23 and Hsp90 in telomerase complexes SE Holt, DL Aisner, J Baur, VM Tesmer, M Dy, M Ouellette, JB Trager, ... Genes & development 13 (7), 817-826, 1999 | 757 | 1999 |
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation DB Yap, J Chu, T Berg, M Schapira, SWG Cheng, A Moradian, RD Morin, ... Blood, The Journal of the American Society of Hematology 117 (8), 2451-2459, 2011 | 727 | 2011 |
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation RA Greenberg, RC O'Hagan, H Deng, Q Xiao, SR Hann, RR Adams, ... Oncogene 18 (5), 1219-1226, 1999 | 559 | 1999 |
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ... New England Journal of Medicine 366 (3), 234-242, 2012 | 529 | 2012 |
Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation RA Greenberg, RC Allsopp, L Chin, GB Morin, RA DePinho Oncogene 16 (13), 1723-1730, 1998 | 447 | 1998 |
Alternative expression analysis by RNA sequencing M Griffith, OL Griffith, J Mwenifumbo, R Goya, AS Morrissy, RD Morin, ... Nature methods 7 (10), 843-847, 2010 | 390 | 2010 |
Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation RC Allsopp, GB Morin, R DePinho, CB Harley, IL Weissman Blood 102 (2), 517-520, 2003 | 381 | 2003 |
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ... The Journal of pathology 226 (1), 7-16, 2012 | 350 | 2012 |
TANK2, a new TRF1-associated poly (ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression PG Kaminker, SH Kim, RD Taylor, Y Zebarjadian, WD Funk, GB Morin, ... Journal of Biological Chemistry 276 (38), 35891-35899, 2001 | 316 | 2001 |
Recognition of a chromosome truncation site associated with α-thalassaemia by human telomerase GB Morin Nature 353 (6343), 454-456, 1991 | 264 | 1991 |
Extending the compatibility of the SP3 paramagnetic bead processing approach for proteomics S Moggridge, PH Sorensen, GB Morin, CS Hughes Journal of proteome research 17 (4), 1730-1740, 2018 | 241 | 2018 |
Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells RC Allsopp, GB Morin, JW Horner, R DePinho, CB Harley, IL Weissman Nature medicine 9 (4), 369-371, 2003 | 201 | 2003 |